Lucid Diagnostics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 11, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	165	45	60	53	198	-
Market Cap Growth	231.39%	-23.95%	12.22%	-73.09%	-	-
Enterprise Value	141	99	63	26	197	-
Last Close Price	1.20	0.82	1.41	1.36	5.37	-
PS Ratio	22.83	10.45	24.58	141.08	395.33	-
PB Ratio	6.40	8.42	-25.83	2.31	3.61	-
P/TBV Ratio	-	-	-	2.71	3.61	-
EV/Sales Ratio	32.09	22.71	25.79	68.61	394.82	-
Debt / Equity Ratio	0.94	3.94	-6.60	0.09	-	-
Asset Turnover	0.12	0.15	0.08	0.01	0.02	-
Inventory Turnover	12.23	22.94	30.74	11.97	0.88	-
Quick Ratio	1.87	1.01	0.71	2.83	12.90	0.02
Current Ratio	1.90	1.07	0.75	2.89	13.45	0.09
Return on Equity (ROE)	-331.24%	-2956.43%	-507.97%	-144.42%	-136.23%	-
Return on Assets (ROA)	-79.17%	-99.28%	-101.38%	-76.84%	-56.01%	-320.54%
Return on Capital Employed (ROCE)	-177.80%	-640.40%	2295.50%	-233.60%	-50.10%	61.30%
Earnings Yield	-39.85%	-100.30%	-88.24%	-105.61%	-14.21%	-
FCF Yield	-26.74%	-97.89%	-55.35%	-57.52%	-9.38%	-
Buyback Yield / Dilution	-80.04%	-20.98%	-15.44%	-94.44%	-31.81%	-0.03%

Updated Nov 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q